Ajooni Biotech Limited (AJOONI) — Capital Reinvestment Ratio

Latest as of September 2025: 0.86x

Ajooni Biotech Limited (AJOONI) has a Capital Reinvestment Ratio of 0.86x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs135.46 Million) in capital expenditures (Rs117.15 Million). Check AJOONI goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.86x
Capex / Operating Cash Flow

Operating Cash Flow

Rs135.46 Million
INR

Capital Expenditures

Rs117.15 Million
INR

Data as of

Sep 2025
Most recent filing

Ajooni Biotech Limited Capital Reinvestment Ratio (2015–2022)

This chart tracks Ajooni Biotech Limited's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see AJOONI cash flow conversion.

Annual Capital Reinvestment Ratio for Ajooni Biotech Limited (2015–2022)

Year-by-year Capital Reinvestment Ratio for Ajooni Biotech Limited from 2015 to 2022. See Ajooni Biotech Limited free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2022 0.58x Rs36.84 Million Rs21.24 Million ▼ -81.1%
2021 3.05x Rs11.56 Million Rs35.27 Million ▲ +122.8%
2015 1.37x Rs1.67 Million Rs2.28 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow